Voyager Therapeutics, Inc. SEC filings VYGR

Voyager Therapeutics, Inc. has 681 filings in SEC EDGAR's recent list, going back to Apr 23, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (officer or director change). The company's fiscal year ends on December 31.

Voyager Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 21, 2026 Oct 20, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Other events
Jul 13, 2026 Jul 13, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 10, 2026 Jun 9, 2026
8-K Current report
Other events
Jun 1, 2026 Jun 1, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 9, 2026
8-K Current report
Officer or director change
Apr 21, 2026 Apr 15, 2026
PRE 14A Preliminary proxy statement Apr 10, 2026 Jun 9, 2026
8-K Current report
Results of operations
Mar 9, 2026 Mar 9, 2026
10-K Annual report Mar 9, 2026 Dec 31, 2025
8-K Current report
Officer or director change, Other events
Feb 12, 2026 Feb 9, 2026
8-K Current report
Regulation FD disclosure
Jan 8, 2026 Jan 8, 2026
EFFECT Filing Dec 1, 2025 —
424B3 Prospectus Dec 1, 2025 —
CORRESP Letter to the SEC Nov 26, 2025 —
S-3 Shelf registration Nov 10, 2025 —
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
8-K Current report
Regulation FD disclosure
Sep 2, 2025 Sep 2, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
S-8 Employee stock plan registration Jun 9, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 5, 2025 Jun 3, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
ARS Annual report to shareholders Apr 23, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 23, 2025 —
DEF 14A Proxy statement Apr 23, 2025 Jun 3, 2025
S-8 Employee stock plan registration Mar 11, 2025 —
10-K Annual report Mar 11, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 11, 2025 Mar 11, 2025
8-K Current report
Other events
Feb 11, 2025 Feb 11, 2025
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Material agreement
Sep 5, 2024 Sep 3, 2024
S-8 Employee stock plan registration Aug 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
8-K Current report
Officer or director change
Jun 13, 2024 Jun 11, 2024
8-K Current report
Shareholder vote results
Jun 6, 2024 Jun 5, 2024
8-K Current report
Other events
May 16, 2024 May 16, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 5, 2024
8-K Current report
Officer or director change
Apr 2, 2024 Mar 27, 2024
8-K Current report
Other events
Mar 13, 2024 Feb 29, 2024
S-8 Employee stock plan registration Feb 28, 2024 —
10-K Annual report Feb 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 28, 2024 Feb 28, 2024
D Filing Jan 17, 2024 —
8-K Current report
Material agreement, Other events
Jan 8, 2024 Jan 3, 2024
424B5 Prospectus supplement Jan 8, 2024 —
424B5 Prospectus supplement Jan 4, 2024 —
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Other events
Jan 2, 2024 Dec 28, 2023
8-K Current report
Other events
Dec 6, 2023 Dec 6, 2023
10-Q Quarterly report Nov 6, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 6, 2023 Nov 6, 2023
8-K Current report
Material agreement, New debt
Aug 16, 2023 Aug 11, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Other events
Jul 10, 2023 Jul 5, 2023
8-K Current report
Shareholder vote results
Jun 7, 2023 Jun 6, 2023
DEFA14A Additional proxy material May 9, 2023 —
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
8-K Current report
Officer or director change
May 9, 2023 May 6, 2023
ARS Annual report to shareholders Apr 27, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 27, 2023 —
DEF 14A Proxy statement Apr 27, 2023 Jun 6, 2023
8-K Current report
Other events
Mar 13, 2023 Mar 13, 2023
S-8 Employee stock plan registration Mar 7, 2023 —
10-K Annual report Mar 7, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 7, 2023 Mar 7, 2023
D Filing Mar 3, 2023 —
8-K Current report
Officer or director change, Other events
Feb 24, 2023 Feb 21, 2023
8-K Current report
Officer or director change
Feb 23, 2023 Feb 22, 2023
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Other events
Jan 9, 2023 Jan 8, 2023
8-K Current report
Officer or director change
Dec 14, 2022 Dec 13, 2022
EFFECT Filing Nov 15, 2022 —
424B3 Prospectus Nov 15, 2022 —
CORRESP Letter to the SEC Nov 10, 2022 —
UPLOAD Letter from the SEC Nov 9, 2022 —
S-3 Shelf registration Nov 8, 2022 —
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Other events
Oct 4, 2022 Oct 4, 2022
8-K Current report
Officer or director change, Other events
Sep 7, 2022 Sep 7, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Officer or director change
Jul 28, 2022 Jul 27, 2022
8-K Current report
Material agreement, Agreement ended
Jun 23, 2022 Jun 22, 2022
8-K Current report
Officer or director change, Shareholder vote results, Other events
Jun 7, 2022 Jun 2, 2022
10-Q Quarterly report May 4, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 4, 2022 May 4, 2022
DEFA14A Additional proxy material Apr 21, 2022 —
DEF 14A Proxy statement Apr 21, 2022 Jun 6, 2022
8-K Current report
Officer or director change
Apr 20, 2022 Apr 14, 2022
8-K Current report
Officer or director change
Mar 22, 2022 Mar 19, 2022
S-8 Employee stock plan registration Mar 8, 2022 —
10-K Annual report Mar 8, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 8, 2022 Mar 8, 2022
CT ORDER Filing Feb 25, 2022 —
8-K Current report
Officer or director change
Feb 3, 2022 Feb 1, 2022
8-K Current report
Officer or director change
Nov 19, 2021 Nov 16, 2021
10-Q Quarterly report Nov 2, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 2, 2021 Nov 2, 2021
8-K Current report
Material agreement
Oct 6, 2021 Oct 1, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 9, 2021 Aug 9, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 8, 2021 Jun 3, 2021
DEFA14A Additional proxy material May 19, 2021 —
8-K Current report
Officer or director change
May 19, 2021 May 14, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 10, 2021 May 10, 2021
DEF 14A Proxy statement Apr 22, 2021 Jun 3, 2021
SEC STAFF LETTER Filing Apr 19, 2021 —
SEC STAFF LETTER Filing Mar 22, 2021 —
S-8 Employee stock plan registration Feb 26, 2021 —
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
8-K Current report
Agreement ended, Other events
Feb 2, 2021 Feb 2, 2021
8-K Current report
Officer or director change
Jan 15, 2021 Jan 15, 2021
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
8-K Current report
Officer or director change
Sep 15, 2020 Sep 14, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
8-K Current report
Agreement ended
Aug 3, 2020 Jul 28, 2020
8-K Current report
Shareholder vote results
Jun 9, 2020 Jun 4, 2020
10-Q Quarterly report May 6, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 6, 2020 May 6, 2020
DEF 14A Proxy statement Apr 22, 2020 Jun 4, 2020
8-K Current report
Material agreement, New debt
Mar 19, 2020 Mar 16, 2020
S-8 Employee stock plan registration Mar 3, 2020 —
10-K Annual report Mar 3, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 3, 2020 Mar 3, 2020
8-K Current report
Officer or director change
Feb 14, 2020 Feb 12, 2020
424B3 Prospectus Dec 3, 2019 —
EFFECT Filing Dec 2, 2019 —
CORRESP Letter to the SEC Nov 27, 2019 —
CORRESP Letter to the SEC Nov 22, 2019 —
UPLOAD Letter from the SEC Nov 19, 2019 —
S-3 Shelf registration Nov 6, 2019 —
10-Q Quarterly report Nov 6, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 6, 2019 Nov 6, 2019
10-Q Quarterly report Aug 9, 2019 Jun 30, 2019
8-K Current report
Results of operations, Officer or director change
Aug 9, 2019 Aug 9, 2019
8-K Current report
Material agreement
Jun 17, 2019 Jun 14, 2019
8-K Current report
Shareholder vote results
Jun 14, 2019 Jun 13, 2019
8-K Current report
Officer or director change
May 21, 2019 May 20, 2019
10-Q Quarterly report May 7, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 7, 2019 May 7, 2019
DEF 14A Proxy statement Apr 23, 2019 Jun 13, 2019
CT ORDER Filing Mar 19, 2019 —
8-K Current report
Other events
Mar 12, 2019 Mar 11, 2019
S-8 Employee stock plan registration Feb 26, 2019 —
10-K Annual report Feb 26, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 26, 2019 Feb 26, 2019
8-K Current report
Material agreement
Feb 22, 2019 Feb 21, 2019
8-K Current report
Material agreement, Unregistered share sale
Jan 29, 2019 Jan 28, 2019
10-Q Quarterly report Nov 7, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 7, 2018 Nov 7, 2018
10-Q Quarterly report Aug 7, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 7, 2018 Aug 7, 2018
8-K Current report
Officer or director change
Jun 29, 2018 Jun 28, 2018
8-K Current report
Shareholder vote results
Jun 15, 2018 Jun 14, 2018
8-K Current report
Material agreement
Jun 5, 2018 Jun 1, 2018
8-K Current report
Officer or director change
May 29, 2018 May 22, 2018
10-Q Quarterly report May 10, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 10, 2018 May 10, 2018
DEF 14A Proxy statement Apr 27, 2018 Jun 14, 2018
CT ORDER Filing Apr 5, 2018 —
S-8 Employee stock plan registration Mar 14, 2018 —
10-K Annual report Mar 14, 2018 Dec 31, 2017
8-K Current report
Results of operations
Mar 14, 2018 Mar 14, 2018
8-K Current report
Material agreement
Feb 20, 2018 Feb 16, 2018
8-K Current report
Material agreement
Feb 7, 2018 Feb 5, 2018
8-K Current report
Officer or director change
Jan 31, 2018 Jan 31, 2018
8-K Current report
Material agreement, Other events
Nov 8, 2017 Nov 7, 2017
424B5 Prospectus supplement Nov 8, 2017 —
424B5 Prospectus supplement Nov 6, 2017 —
10-Q Quarterly report Nov 2, 2017 Sep 30, 2017
8-K Current report
Results of operations
Nov 2, 2017 Nov 2, 2017
8-K Current report
Officer or director change
Sep 18, 2017 Sep 18, 2017
10-Q Quarterly report Aug 8, 2017 Jun 30, 2017
8-K Current report
Results of operations
Aug 8, 2017 Aug 8, 2017
8-K Current report
Shareholder vote results
Jun 21, 2017 Jun 19, 2017
10-Q Quarterly report May 9, 2017 Mar 31, 2017
8-K Current report
Results of operations
May 9, 2017 May 9, 2017
DEF 14A Proxy statement Apr 25, 2017 Jun 19, 2017
S-8 Employee stock plan registration Mar 15, 2017 —
10-K Annual report Mar 15, 2017 Dec 31, 2016
8-K Current report
Results of operations
Mar 15, 2017 Mar 15, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
VYGR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Lexington, MA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1640266

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.